Domo 1 year target
What is the 1 year target of Domo?
The 1 year target of Domo Inc. is $47 +549.72%
What is the definition of 1 year target?
1 year target is a predicted stock price a year from now.
= average of analyst price targets
One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.
1 year target of companies in the Technology sector on NASDAQ compared to Domo
What does Domo do?
domo optimizes your business by connecting you to the data, people, and expertise you need to improve business results. domo helps every employee – from the ceo to the front line worker – optimize business performance by connecting them to the right data and people they need to improve business results. the company is backed with more than $500 million from the world’s best investors and is led by a management team with tenure at the world’s most well-known technology companies.
Companies with 1 year target similar to Domo
- ITL Industries has 1 year target of ₨47 -90.00%
- Docebo has 1 year target of $47 +13.83%
- Truist has 1 year target of $47 +12.97%
- Lightspeed POS has 1 year target of CAD$62 +260.41%
- Iovance Biotherapeutics Inc has 1 year target of $47 +403.64%
- Rothschild & Co. SCA has 1 year target of €47 +22.89%
- Domo has 1 year target of $47 +549.72%
- Leggett & Platt has 1 year target of $47 +307.68%
- WestRock Co has 1 year target of $47 -8.27%
- United Natural Foods has 1 year target of $47 +225.78%
- EasyVista S.A has 1 year target of €47 -32.43%
- Pennant Inc has 1 year target of $47 +40.78%
- Innovent Biologics has 1 year target of HKD$55 +27.91%